Search Results - "Drobacheff‐Thiébaut, C."

Refine Results
  1. 1

    Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort by Cuzin, Lise, Pugliese, Pascal, Katlama, Christine, Bani-Sadr, Firouzé, Ferry, Tristan, Rey, David, Lourenco, Jeremy, Bregigeon, Sylvie, Allavena, Clotilde, Reynes, Jacques, Cabié, André

    Published in Journal of antimicrobial chemotherapy (01-03-2019)
    “…Abstract Objectives To analyse the frequency and causes of treatment discontinuation in patients who were treated with an integrase strand transfer inhibitor…”
    Get full text
    Journal Article
  2. 2
  3. 3

    No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy by Makinson, Alain, Arvieux, Cedric, Chirouze, C., Brunel, AS, Chevalier, E., Mrozek, N., Aumeran, C., Goncalvez, E., Lamaury, I., Ouissa, R., Receveur, MC, Clavel, C., Markowicz, S., Merrien, D., Guimard, T., Bollangier, O., Boucher, D., Boibieux, A., Cannesson, O., Chiarello, P., Ferry, T., Pouderoux, C., Triffault‐Fillit, C., Valour, F., Charre, C., Trabaud, M.A., Belkhir, AY, Madrid, A., Tissot‐Dupont, H., Brégigeon, S., Ducassou, M.J., Galie, S., Colson, H., Ivanova, A., Debreux, C., Cabras, O., Dupin de Majoubert, R., Najioullah, F., Pasquier, J., Varache, C., Atoui, N., Montes, B., Lefèvre, B., Jeanmaire, E., Hénard, S., Frentiu, E., Bouillon, MP, Raffi, F., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Deschanvres, C., Grossi, O., Morineau, P., Soria, A., Pugliese, P., Chirio, D., Cua, E., Dellamonica, P., De Monte, A., Durant, J., Maka, A., Giaché, S., Lerolle, N., Deradji, O., Castro, A., Ghosn, J., Lescure, FX, Le Gac, S., Duvivier, C., Alby‐Laurent, F., Amazzough, K., Bossi, P., Jidar, K., Lafont, E., Lourenco, J., Valantin, MA, Blanc, C., Katlama, C., Romaru, J., Tattevin, P., Souala, F., Benezit, F., Pronier, C., Morlat, C., Poisson‐Vannier, M., Jovelin, T., Frésard, A., Ronat, V., Lucht, F., Batard, ML, Delobel, P., Biezunski, N., Martin‐Blondel, G., Piffaut, M., Saune, K., Ajana, F., Baclet, V., Pradier, M.

    Published in HIV medicine (01-03-2022)
    “…Objectives Our aim was to assess if switching from a protease inhibitors (PI)‐based regimen to a PI‐free one is associated with an increased risk of Kaposi…”
    Get full text
    Journal Article
  4. 4

    Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015 by Poizot‐Martin, I., Obry‐Roguet, V., Lions, C., Huleux, T., Ferry, T., Allavena, C., Bani‐Sadr, F., Lamaury, I., Brégigeon, S., Muret, P., Lesens, O., Prouteau, J., Bonijoly, T., Daniel, C., Perré, P., Guimard, T., Becker, A., Boibieux, A., Cotte, L., Degroodt, S., Colson, P., Meddeb, L., Mokhtari, M., Motte, A., Raoux, A., Ravaux, I., Tamalet, C., Tissot Dupont, H., Orticoni, M., Galinier, A., Martinet, P., Abel, S., Cabras, O., Cuzin, L., Guitteaud, K., Pierre‐François, S., Osei, L., Atoui, N., Boyer, L., Hoen, B., Bernaud, C., Biron, C., Hall, N., Ferré, V., André‐Garnier, E., Rodallec, A., Lefebvre, M., Aubry, O., Breaud, S., Chirio, D., Garraffo, R., Mondain, V., Naqvi, A., Perbost, I., Pradier, C., Prouvost‐Keller, B., Roger, P.M., Wehrlen‐Pugliese, S., Hocqueloux, L., Sève, A., Boulard, C., Goujard, C., Quertainmont, Y., Teicher, E., Deradji, O., Rioux, C., Lariven, S., Lescure, F.X., Le Gac, S., Charpentier, C., Peytavin, G., Bossi, P., Cessot, G., Consigny, P.H., Danion, F., Goesch, J., Lanternier, F., Pilmis, B., Touam, F., Berger, J.L., Brodard, V., Revest, M., Lemaitre, F., Poisson‐Vanier, M., Jovelin, T., Fischer, P., Cheneau, C., Mautort, E., Fafi‐Kremer, S., Alvarez, M., Biezunski, N., Debard, A., Lansalot, P., Saune, K., Aïssi, E., Baclet, V., Pradier, M., Robineau, O., Viget, N., Valette, M.

    “…Background Although antiretroviral therapy (ART) has reduced the risk of Kaposi sarcoma (KS), KS cases still occur in HIV‐infected people. Objective To…”
    Get full text
    Journal Article
  5. 5

    Comparative risk of failure of ABC/3TC or TDF/FTC based first‐line regimens in patients with a high viral load by Flandre, P, Pugliese, P, Allavena, C, Katlama, C, Cotte, L, Cheret, A, Cabié, A, Rey, D, Chirouze, C, Cuzin, L, Obry‐Roguet, V., Bregigeon, S., Poizot‐Martin, I., Marchou, B., Massip, P., Bonnet, E., Obadia, M., Alvarez, M., Porte, L., Delobel, P., Chauveau, M., Garipuy, D., Bernard, J., Lepain, I., Marcel, M., Puntis, E., Sauné, K., Ceppi, C., Cua, E., Cottalorda, J., Dellamonica, P., Demonchy, E., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Mondain, V., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Wehrlen‐Pugliese, S., Sausse, S., Roger, P.M., Bernaud, C., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Hall, N., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Larmet, L., Pineau, So, Ferré, V., André‐Garnier, E., Rodallec, A., Choisy, P., Yazdanpanah, Y., Landman, R., Duvivier, C., Agher, R., Consigny, P.H., Cessot, G., Touam, F., Usubillaga, R., Benhadj, K., Abel, S., Pierre‐François, S., Ouka, M., Martial, J., Ebel, E., Cheneau, C, Priester, M, Batard, ML, Bernard‐Henry, C, Mautort, E, DrobacheffThiébaut, C., Faller, J.P., Faucher, J.F., Foltzer, A., Jacomet, C., Laurichesse, H., Lesens, O., Aumeran, C., Baud, O., Beytout, J., Coban, D., Casanova, S., Rouger, C., Peyramond, D., Chidiac, C., Ader, F., Boibieux, A., Miailhes, P, Perpoint, T.

    Published in HIV medicine (01-05-2016)
    “…Objectives To compare the efficacy, in current clinical practice, of first regimens containing abacavir with lamivudine (ABC/3TC) or tenofovir with…”
    Get full text
    Journal Article
  6. 6

    Hepatitis C virus incidence in HIV‐infected and in preexposure prophylaxis (PrEP)‐using men having sex with men by Cotte, Laurent, Raffi, François, Gagneux‐Brunon, Amandine, Palich, Romain, Hoen, Bruno, Ferry, T., Boibieux, A., Miailhes, P., Valour, F., Schlienger, I., Lippmann, J., Braun, E., Longuet, C., Brochier, C., Degroodt, S., Breaud, S., Ceppi, C., Courjon, J., Cottalorda, J., Cottalorda, J., Demonchy, E., Durant, J., Durant, J., Etienne, C., Etienne, C., Fuzibet, J. G., Risso, K., Mondain, V., Oran, N., Pillet, S., Prouvost‐Keller, B., Brégigeon, S., Orticoni, M., Jaquet, I., Galie, S., Martinet, P., Ivanova, A., Debreux, C., Lions, C., Quertainmont, Y., Teicher, E., Vittecoq, D., Deradji, O., Barrail‐Tran, A., Consigny, P. H., Cessot, G., Goesch, J., Benabdelmoumen, G., Lanternier, F., Charlier, C., Rouzaud, C., Touam, F., Louisin, C., Duvivier, C., Lortholary, O., Danion, F., Biezunski, N., Delpierre, C., Piffaut, M., Merle de Boever, C., Montes, B., Montoya Ferrer, A., Tribout, V., Allavena, C., Biron, C., Brunet‐Cartier, C., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Sécher, S., Ferré, V., Grossi, O., Boucher, A., Huleux, T., Lafon‐Desmurs, B., Pradier, M., Robineau, O., Berger, J. L., Lebrun, D., Bani‐Sadr, F., Fischer, P., Partisani, M., Priester, M., Bernard‐Henry, C., Mautort, E., Frésard, A., Baud, O., Corbin, V., Casanova, S., DrobacheffThiébaut, C., Muret, P., Abel, S., Césaire, R., Cuzin, L., Nguyen, D., Pierre‐François, S., Fabre, I., Curlier, E., Herrmann‐Storck, C.

    Published in Liver international (01-10-2018)
    “…Background & Aims HCV incidence still appears on the rise in HIV‐infected MSM in France. We assessed the incidence of HCV infection in HIV‐positive and in…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018 by Cotte, Laurent, Hocqueloux, Laurent, Lefebvre, Maeva, Pradat, Pierre, Bani-Sadr, Firouze, Huleux, Thomas, Poizot-Martin, Isabelle, Pugliese, Pascal, Rey, David, Cabié, André

    Published in Clinical infectious diseases (02-11-2021)
    “…Abstract Background The arrival of highly effective, well-tolerated, direct-acting antiviral agents (DAA) led to a dramatic decrease in hepatitis C virus (HCV)…”
    Get full text
    Journal Article
  9. 9
  10. 10

    No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study by Cuzin, Lise, Allavena, Clotilde, Cotte, Laurent, Delpierre, Cyrille, Huleux, Thomas, Palich, Romain, Delobel, Pierre, Raffi, François, Cabié, André

    Published in Journal of antimicrobial chemotherapy (01-06-2021)
    “…Abstract Objectives Even in an ‘optimal’ health system, patients’ characteristics may have an impact on their care. We investigated whether age, gender and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Ageing with HIV: do comorbidities and polymedication drive treatment optimization? by Cuzin, L, Katlama, C, Pugliese, P, Bernaud, C, Rey, D, Chirouze, C, Bani‐Sadr, F, Cabié, A, Zaegel‐Faucher, O., Orticoni, M., Luquet‐Besson, I., Ressiot, E., Carta‐ Padovani, M., Bertone, H., Galie, S., Monclar, M., Ritleng, A. S., Ivanova, A., Marchou, B., Massip, P., Obadia, M., Alvarez, M., Martin‐Blondel, G., Chauveau, M., Garipuy, D., Labau, E., Puntis, E., Ceppi, C., Cua, E., Dellamonica, P., Demonchy, E., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Mondain, V., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Wehrlen‐Pugliese, S., Rosenthal, E., Sausse, S., Roger, P. M., Allavena, C., Billaud, E., Biron, C., Bouchez, S., Boutoille, D., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Larmet, L., Pineau, S., Ferré, V., André‐Garnier, E., Rodallec, A., Lefebvre, M., Point, P., Choisy, P., Yazdanpanah, Y., Landman, R., Valantin, M. A., Agher, R., Lortholary, O., Avettand‐Fenoel, V., Rouzioux, C., Touam, F., Usubillaga, R., Benhadj, K., Abel, S., Martial, J., Fischer, P., Partisani, M., Cheneau, C., Priester, M., Batard, M. L., Foltzer, A., Hoen, B., Jacomet, C., Laurichesse, H., Lesens, O., Vidal, M., Mrozek, N., Baud, O., Beytout, J., Coban, D., Casanova, S., Berger, J. L., N'Guyen, Y., Lambert, D., Kmiec, I., Hentzien, M., Chidiac, C., Ader, F., Ferry, T., Miailhes, P., Perpoint, T., Degroodt, S.

    Published in HIV medicine (01-07-2017)
    “…Objectives The aim of the study was to describe the ageing HIV‐infected population (> 50 years old) and their current antiretroviral therapy (ART),…”
    Get full text
    Journal Article
  13. 13

    Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort by Cuzin, Lise, Pugliese, Pascal, Katlama, Christine, Bani-Sadr, Firouzé, Ferry, Tristan, Rey, David, Lourenco, Jeremy, Bregigeon, Sylvie, Allavena, Clotilde, Reynes, Jacques, Cabié, André, Drobacheff-Thiébaut, C, Foltzer, A, Bouiller, K, Hustache-Mathieu, L, Chirouze, C, Lepiller, Q, Bozon, F, Babre, O, Muret, P, Laurichesse, H, Lesens, O, Vidal, M, Mrozek, N, Aumeran, C, Baud, O, Corbin, V, Letertre, P, Casanova, S, Jacomet, C, Hoen, B, Lamaury, I, Fabre, I, Curlier, E, Ouissa, R, Schepers, K, Herrmann-Storck, C, Dournon, N, Merrien, D, Perré, P, Guimard, T, Bollangier, O, Leautez, S, Morrier, M, Ader, F, Biron, F, Boibieux, A, Cotte, L, Ferry, T, Miailhes, P, Perpoint, T, Roux, S, Degroodt, S, Brochier, C, Valour, F, Chidiac, C, Dhiver, C, Mokhtari, M Saadia, Ménard, A, Dupont, H Tissot, Toméi, C, Meddeb, L, Belkhir, A, Ravaux, I, Brégigeon, S, Zaegel-Faucher, O, Obry-Roguet, V, Orticoni, M, Soavi, M, Luquet-Besson, I, Ressiot, E, Carta-Padovani, M, Ducassou, M, Bertone, H, Galie, S, Galinier, A, Monclar, M, Ritleng, A, Ivanova, A, Blanco-Betancourt, C, Lions, C, Poizot-Martin, I, Abel, S, Césaire, R, Cuzin, L, Santos, G Dos, Fagour, L, Illiaquer, M, Najioullah, F, Nguyen, D, Ouka, M, Pierre-François, S, Pasquier, J, Pircher, M, Rozé, B, Cabié, A, Atoui, N, Moing, V Le, Makinson, A, Meftah, N

    Published in Journal of antimicrobial chemotherapy (01-03-2019)
    Get full text
    Journal Article
  14. 14

    Characteristics and consequences of medical care interruptions in HIV-infected patients in France by CUZIN, L., DELLAMONICA, P., YAZDANPANAH, Y., BOUCHEZ, S., REY, D., HOEN, B., CABIÉ, A.

    Published in Epidemiology and infection (01-08-2016)
    “…To describe the consequences of medical care interruptions (MCIs) we selected patients with at least two medical encounters between January 2006 and June 2013…”
    Get full text
    Journal Article
  15. 15

    An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy by Pugliese, P, Delpierre, C, Cuzin, L, Poizot‐Martin, I, Rey, D, Saune, K, Cottalorda, J, Bettinger, D, Delaugerre, C, Hoen, B

    Published in HIV medicine (01-09-2013)
    “…Objectives The aim of the study was to assess whether patients with undetectable viraemia [a negative polymerase chain reaction result (PCRneg)] and those with…”
    Get full text
    Journal Article
  16. 16

    Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection by Gantner, Pierre, Cotte, Laurent, Allavena, Clotilde, Bani-Sadr, Firouzé, Huleux, Thomas, Duvivier, Claudine, Valantin, Marc-Antoine, Jacomet, Christine, Joly, Véronique, Chéret, Antoine, Pugliese, Pascal, Delobel, Pierre, Cabié, André, Rey, David

    Published in PloS one (18-04-2019)
    “…Achieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B…”
    Get full text
    Journal Article
  17. 17

    Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort by Lions, C, Cabras, O, Cotte, L, Huleux, T, Gagneux-Brugnon, A, Makinson, A, Cabié, A, Bonnet, B, Duvivier, C, Hocqueloux, L, Cua, E, Cheret, A, Hustache-Mathieu, L, Obry-Roguet, V, Jacomet, C, Poizot-Martin, I

    Published in BMC infectious diseases (25-03-2019)
    “…HIV pre-exposure prophylaxis (PrEP) was implemented in France in November 2015 based on individual-level risk factors for HIV infection. We evaluated the…”
    Get full text
    Journal Article
  18. 18

    Pregnancy may be followed by an inflexion of the immune reconstitution in HIV‐infected women who receive antiretroviral drugs before conception by Le Moing, V, Taïeb, A, Longuet, P, Lewden, C, Delcey, V, Drobacheff, MC Thiebaut, Chêne, G, Leport, C

    Published in HIV medicine (01-11-2008)
    “…Background Whether pregnancy has an impact on the evolution of CD4 cell counts in women treated with highly potent antiretrovirals before conception remains…”
    Get full text
    Journal Article
  19. 19

    Effets de l’imiquimod sur l’infection périanale latente à papillomavirus humain chez des malades infectés par le virus de l’immunodéficience humaine by Pelletier, F., Drobacheff-Thiebaut, C., Aubin, F., Venier, A.-G., Mougin, C., Laurent, R.

    “…Les papillomavirus humains (HPV) à haut risque sont considérés comme des facteurs de risque du cancer anal dont l’incidence est plus élevée chez les malades…”
    Get full text
    Journal Article
  20. 20